8-K
filed May 15, 2025, 7:59 PM ET
CIK 0001564824
M&A
confidence high
sentiment neutral
materiality 0.85
Allakos Inc.: M&A transaction — Allakos acquired by Concentra Biosciences for $0.33/share; delisting from Nasdaq
Allakos Inc.
- Allakos acquired by Concentra Biosciences via tender offer and merger for $0.33 per share in cash.
- Approximately 81.21% of outstanding shares tendered; all conditions satisfied.
- Merger completed May 15, 2025; Allakos now a wholly owned subsidiary of Concentra.
- Allakos board and officers resigned; replaced by Kevin Tang and other Concentra executives.
- Trading of ALLK shares suspended; company to file Form 25 to delist and deregister.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Alexander resigned as Director at Allakos Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Robert Alexander, Ph.D., Robert E. Andreatta, Neil Graham, M.D., Steven P. James, Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dolca Thomas resigned as Director at Allakos Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Dolca Thomas, M.D. and Paul Walker resigned from the board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Thomas Wei was appointed as Chief Business Officer at Allakos Inc..
- Action
- became
- Role
- Chief Business Officer
Exact text from the filing
Thomas Wei, Chief Business Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paul Walker resigned as Director at Allakos Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Paul Walker resigned from the board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Alexander resigned as Officer at Allakos Inc..
- Action
- resigned
- Role
- Officer
Exact text from the filing
Dr. Alexander, Baird Radford and Adam Tomasi have resigned from their respective positions as officers of the Company
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Baird Radford resigned as Officer at Allakos Inc..
- Action
- resigned
- Role
- Officer
Exact text from the filing
Baird Radford and Adam Tomasi have resigned from their respective positions as officers of the Company
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Amy L. Ladd resigned as Director at Allakos Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ryan Cole was appointed as Chief Operating Officer at Allakos Inc..
- Action
- became
- Role
- Chief Operating Officer
Exact text from the filing
Ryan Cole, Chief Operating Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Hearne was appointed as Chief Financial Officer at Allakos Inc..
- Action
- became
- Role
- Chief Financial Officer
Exact text from the filing
Michael Hearne, Chief Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Steven P. James resigned as Director at Allakos Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Steven P. James, Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Adam Tomasi resigned as Officer at Allakos Inc..
- Action
- resigned
- Role
- Officer
Exact text from the filing
Adam Tomasi have resigned from their respective positions as officers of the Company
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert E. Andreatta resigned as Director at Allakos Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Robert E. Andreatta, Neil Graham, M.D., Steven P. James, Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kevin Tang was appointed as Director at Allakos Inc..
- Action
- became
- Role
- Director
Exact text from the filing
The sole director of Merger Sub immediately prior to the Effective Time was Kevin Tang
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kevin Tang was appointed as Chief Executive Officer at Allakos Inc..
- Action
- became
- Role
- Chief Executive Officer
Exact text from the filing
Mr. Tang, Chief Executive Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Stew Kroll was appointed as Chief Development Officer at Allakos Inc..
- Action
- became
- Role
- Chief Development Officer
Exact text from the filing
Stew Kroll, Chief Development Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Neil Graham resigned as Director at Allakos Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Neil Graham, M.D., Steven P. James, Amy L. Ladd, M.D., Dolca Thomas, M.D. and Paul Walker resigned from the board of directors
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Allakos Inc. underwent a change of control involving Concentra Biosciences, LLC for $0.33 per Share in cash (closed 2025-05-15).
- Action
- change of control
- Counterparty
- Concentra Biosciences, LLC
- Consideration
- $0.33 per Share in cash
- Closing
- 2025-05-15
Exact text from the filing
15, 2025, Merger Sub completed a tender offer to purchase all of the C ompany’s outstanding shares of common stock, par value $0.001 per share (the “ Shares ”), in exchange for $0.33 in cash per Share (the “ Offer Price ”), subject to and in accordance with the terms and conditions set forth in the Offer to Purchase, dated April 15, 2025 (the “ Offer to
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.